⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11437920 | 0.58 | — | — | |
| SCHEMBL7269174 | 0.58 | — | — | |
| SCHEMBL33542 | 0.57 | — | — | |
| SCHEMBL692145 | 0.55 | — | — | |
| SCHEMBL22887752 | 0.55 | — | — | |
| SCHEMBL12748335 | 0.54 | — | — | |
| SCHEMBL8471687 | 0.54 | — | — | |
| SCHEMBL9472 | 0.49 | — | — | |
| SCHEMBL790604 | 0.48 | — | — | |
| SCHEMBL766955 | 0.48 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021071843-A1 | MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS | Pipeline Therapeutics, Inc. (US) | 2021-04-15 | — | — | WO | disclosed |
| US-20170360952-A1 | BIOMOLECULE CONJUGATES | CELGENE CORPORATION | 2017-12-21 | — | — | US | disclosed |
| EP-2940008-B1 | NOVEL BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | SANWA KAGAKU KENKYUSHO CO (JP) | 2017-05-17 | — | — | EP | disclosed |